Skip to main content

BioPlus Acquisition Corp.

BIOSDelisted Oct 6, 2023
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0001856653

BioPlus Acquisition Corp. was delisted on Oct 6, 2023; its insiders filed their last Form 4 on Jun 12, 2023; 30 institutions reported holding it in 13F filings for Q3 2023, worth $135.2M in total; no superinvestor held it.

Holders of 5% or more of BIOS

Holders whose latest Schedule 13D or 13G filing reports 5% or more of BioPlus Acquisition Corp., largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of BioPlus Acquisition Corp. on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

16 Schedule 13D and 13G filings on BioPlus Acquisition Corp., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on BIOS
Filed (ET)FilerFormStakeChangeEvent dateFiling
Feb 12, 2024Cantor Fitzgerald Securities13G/AOld format–––SEC
Feb 9, 2024Polar Asset Management Partners Inc.13G/AOld format–––SEC
Feb 7, 2024Saba Capital Management, L.P.13G/AOld format–––SEC
Jan 19, 2024Highbridge Capital Management LLC13G/AOld format–––SEC
Jun 13, 2023BioPlus Sponsor LLC13D/AOld format–––SEC
Feb 14, 2023Cantor Fitzgerald Securities13G/AOld format–––SEC
Feb 14, 2023Saba Capital Management, L.P.13G/AOld format–––SEC
Feb 9, 2023Polar Asset Management Partners Inc.13GOld format–New–SEC
Feb 2, 2023Highbridge Capital Management LLC13GOld format–––SEC
Nov 2, 2022Cantor Fitzgerald Securities13GOld format–New–SEC
Feb 14, 2022Saba Capital Management, L.P.13G/AOld format–––SEC
Feb 9, 2022MMCAP International Inc. SPC13G/AOld format–––SEC
Dec 17, 2021BioPlus Sponsor LLC13DOld format–New–SEC
Dec 13, 2021Saba Capital Management, L.P.13GOld format–New–SEC
Dec 10, 2021MMCAP International Inc. SPC13GOld format–New–SEC
Dec 10, 2021Highbridge Capital Management LLC13GOld format–New–SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell BioPlus Acquisition Corp. shares.

No Form 144 notices for BioPlus Acquisition Corp. are on file.